Jennifer Jarrett
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Arcus Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Zura Bio Limited June 17, 202670.7%
-
Sagimet Biosciences Inc. June 12, 202671.7%
-
Zura Bio Limited May 21, 202596.3%
-
Zura Bio Limited October 23, 202499.6%
-
Syndax Pharmaceuticals Inc. May 14, 202463.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2026 | Damora Therapeutics Inc. | Open-market purchase | +12,500 | $20.23 | $252,875 |
| Mar 30, 2026 | Damora Therapeutics Inc. | Grant or award | +500,000 | — | — |
| Feb 4, 2026 | Syndax Pharmaceuticals Inc. | Grant or award | +24,000 | — | — |
| Jan 23, 2026 | Arcus Biosciences Inc. | Grant or award | +31,000 | — | — |
| Dec 17, 2025 | Arcus Biosciences Inc. | Open-market sale | −9,983 | $22.16 | $221,223 |
| Dec 16, 2025 | Arcus Biosciences Inc. | Open-market sale | −11,225 | $21.88 | $245,603 |
| Nov 7, 2025 | Arcus Biosciences Inc. | Option exercise | +50,291 | $1.23 | $61,858 |
| Nov 7, 2025 | Arcus Biosciences Inc. | Open-market sale | −50,291 | $18.97 | $954,020 |
| Oct 8, 2025 | Arcus Biosciences Inc. | Option exercise | +37,792 | $1.23 | $46,484 |
| Oct 8, 2025 | Arcus Biosciences Inc. | Open-market sale | −37,792 | $15.05 | $568,770 |
| Oct 6, 2025 | Arcus Biosciences Inc. | Option exercise | +12,500 | $1.23 | $15,375 |
| Oct 6, 2025 | Arcus Biosciences Inc. | Open-market sale | −12,500 | $14.54 | $181,750 |
| Feb 5, 2025 | Syndax Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
| Jan 23, 2025 | Arcus Biosciences Inc. | Grant or award | +50,000 | — | — |
| Dec 15, 2024 | Arcus Biosciences Inc. | Shares withheld for tax | −27,501 | $16.08 | $442,216 |
Questions about Jennifer Jarrett
What boards is Jennifer Jarrett on?
Jennifer Jarrett sits on the boards of Arcus Biosciences Inc., Damora Therapeutics Inc., Sagimet Biosciences Inc., Syndax Pharmaceuticals Inc. and Zura Bio Limited.
What company is Jennifer Jarrett the CEO of?
Jennifer Jarrett is Director, President and CEO of Damora Therapeutics Inc.
How long has Jennifer Jarrett served on boards?
Our records show at least 14 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.